Chromosomal abnormality rates at amniocentesis and in live-born infants

E. B. Hook, P. K. Cross and D. M. Schreinemachers

Regression-smoothed maternal age-specific rates of six different categories of cytogenetic abnormalities in recent large-scale prenatal cytogenetic studies were multiplied by independently derived fetal selection coefficients--factors that adjust for the excess likelihood of spontaneous loss of cytogenetically abnormal fetuses--to obtain estimated maternal age-specific rates of these categories of cytogenetic abnormalities in live-born infants. The derived rates apply to women whose only risk factor is advanced maternal age. The categories analyzed were 47,+21 (Down's syndrome), 47,+18 (Edwards' syndrome), 47,+13 (Patau's syndrome), 47,XXY (Klinefelter's syndrome), 47,XXX, and the group of other clinically significant abnormalities considered collectively. The rate of all clinically significant abnormalities considered together derived in this study was about five per 1,000 at age 35 years, 15 per 1,000 at age 40 years, and 50 per 1,000 at age 45 years.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities
Li et al.
Hum Mol Genet 2007;16:1359-1366.
ABSTRACT | FULL TEXT  

Challenging the Strategy of Maternal Age-Based Prenatal Genetic Counseling
Berkowitz et al.
JAMA 2006;295:1446-1448.
FULL TEXT  

Screening for Down Syndrome: Practice Patterns and Knowledge of Obstetricians and Gynecologists
Cleary-Goldman et al.
Obstet Gynecol 2006;107:11-17.
ABSTRACT | FULL TEXT  

Mothers of Children With Down Syndrome Reflect on Their Postnatal Support
Skotko
Pediatrics 2005;115:64-77.
ABSTRACT | FULL TEXT  

Advanced Maternal Age -- How Old Is Too Old?
Heffner
NEJM 2004;351:1927-1929.
FULL TEXT  

Diagnostic Performance of Intracardiac Echogenic Foci for Down Syndrome: A Meta-analysis
Sotiriadis et al.
Obstet Gynecol 2003;101:1009-1016.
ABSTRACT | FULL TEXT  

Population-Based Analyses of Mortality in Trisomy 13 and Trisomy 18
Rasmussen et al.
Pediatrics 2003;111:777-784.
ABSTRACT | FULL TEXT  

Second-Trimester Ultrasound to Detect Fetuses With Down Syndrome: A Meta-analysis
Smith-Bindman et al.
JAMA 2001;285:1044-1055.
ABSTRACT | FULL TEXT  

Neonatal Outcome of Preimplantation Genetic Diagnosis by Polar Body Removal: The First 109 Infants
Strom et al.
Pediatrics 2000;106:650-653.
ABSTRACT | FULL TEXT  

Cost-Benefit Analysis of Prenatal Diagnosis for Down Syndrome Using the British or the American Approach
VINTZILEOS et al.
Obstet Gynecol 2000;95:577-583.
ABSTRACT | FULL TEXT  

Ultrasound Findings and Multiple Marker Screening in Trisomy 18
BRUMFIELD et al.
Obstet Gynecol 2000;95:51-54.
ABSTRACT | FULL TEXT  

Assessment of multiplex fluorescent PCR for screening single cells for trisomy 21 and single gene defects
Blake et al.
Mol Hum Reprod 1999;5:1166-1175.
ABSTRACT | FULL TEXT  

The Use of Ultrasound to Identify Fetuses with Down Syndrome: Case Study and Review
Durbin
Journal of Diagnostic Medical Sonography 1999;15:107-111.
ABSTRACT  

Patient or Physician Preferences for Decision Analysis: The Prenatal Genetic Testing Decision
Heckerling et al.
Med Decis Making 1999;19:66-77.
ABSTRACT  

Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for Screening
Haddow et al.
NEJM 1994;330:1114-1118.
ABSTRACT | FULL TEXT  

Prenatal Diagnosis
D'Alton and DeCherney
NEJM 1993;328:114-120.
FULL TEXT  

Antenatal Sonographic Findings in Trisomy 21
Clark et al.
Journal of Diagnostic Medical Sonography 1992;8:316-319.
ABSTRACT